Vitrakvi

Bayer at ASCO: Vitrakvi Effective in TRK Fusion Cancers Regardless of Tumor Type
BioSpace
Sun, 06/6/21 - 10:31 pm
Bayer
ASCO 2021
Vitrakvi
cancer
Tumour-agnostic drugs ‘game-changing’, says NICE as it rejects one from Bayer
Pharmaforum
Fri, 01/17/20 - 12:07 pm
cancer
UK
NICE
Bayer
Vitrakvi
drug pricing
Bayer’s Vitrakvi is first tumour-agnostic drug approved in EU
Pharmaforum
Tue, 09/24/19 - 09:28 am
Bayer
TRK inhibitors
Vitrakvi
Europe
tumor agnostic drugs
cancer
Bayer to work with Foundation Medicine on selecting cancer patients
Reuters
Wed, 05/29/19 - 11:01 pm
Bayer
Foundation Medicine
Roche
cancer
Vitrakvi
genetic sequencing
Roche, Bayer unveil brain tumor data for NTRK inhibitors ahead of ASCO
BioCentury
Fri, 05/17/19 - 10:05 am
Roche
Bayer
brain cancer
entrectinib
Vitrakvi
Bayer acquires full Vitrakvi rights from Eli Lilly's Loxo
Yahoo/Reuters
Fri, 02/15/19 - 10:27 am
Bayer
Vitrakvi
cancer
Eli Lilly
Loxo Oncology
Is Eli Lilly Overpaying for Loxo Oncology?
Motley Fool
Tue, 01/8/19 - 09:30 am
Eli Lilly
Loxo Oncology
M&A
Vitrakvi
5 Things You Need to Know About Loxo Oncology's Revolutionary New Cancer Drug
Motley Fool
Wed, 11/28/18 - 10:08 am
Loxo Oncology
Vitrakvi